Short-term hormone therapy suspension and mammography recall: a randomized trial.

ABSTRACT:

Background

Without population-based evidence, some clinicians recommend short-term suspension of hormone therapy to improve the performance of mammography. Hormone therapy increases breast density, and abnormal screening mammograms are more common among women with denser breasts and among women using hormone therapy.

Objective

To test whether 1 to 2 months of hormone therapy suspension before screening mammography decreases additional mammographic imaging (recall) in women age 45 to 80 years.

Design

3-group randomized, controlled trial.

Setting

Integrated health plan in western Washington from 2004 to 2007.

Patients

1704 women age 45 to 80 years who used hormone therapy at their most recent screening (index) mammography, were due for screening (study) ma

SUBMITTER: Buist DS 

PROVIDER: S-EPMC2803099 | biostudies-literature | 2009 Jun

REPOSITORIES: biostudies-literature